New tablet tool aims to boost PrEP use among black women in the south

NCT ID NCT07398482

Not yet recruiting Prevention Sponsor: Boston University Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a tablet-based tool called PrEPwise, delivered by community health workers, to help Black women in eastern Virginia learn about and decide whether to start PrEP (a daily pill that prevents HIV). The trial will enroll 108 Black women who are eligible for PrEP and seek HIV testing. Researchers want to see if the tool is acceptable, feasible, and leads to more women starting PrEP.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: PrEPwise (tablet-based decision aid delivered by community health workers)
What this could lead to: If successful, this tool could help more Black women learn about and start PrEP, potentially reducing new HIV cases in this community.
What could go wrong: This is a small feasibility study (108 people) testing whether the tool is acceptable and practical, not whether it prevents HIV. Results may not apply to other regions or groups.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV INFECTIONS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

sexually transmitted disease HIV infectious disease prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HIV INFECTIONS SEXUALLY TRANSMITTED INFECTION

Contacts and locations

Locations

LGBT Life Center (5360 Robin Hood Road, Norfolk, VA 23513

Norfolk, Virginia, 23513, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.